U Smailovic, V Jelic - Neurology and therapy, 2019 - Springer
Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly mirror AD-associated molecular and structural brain changes. While they are necessary for …
F Vecchio, C Babiloni, R Lizio, FDV Fallani… - Supplements to Clinical …, 2013 - Elsevier
The human brain contains an intricate network of about 100 billion neurons. Aging of the brain is characterized by a combination of synaptic pruning, loss of cortico-cortical …
Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly with a progressive decline in cognitive function significantly affecting quality of life …
GG Yener, E Başar - Supplements to Clinical neurophysiology, 2013 - Elsevier
Alzheimer's disease (AD) is a devastating neurodegenerative dementing illness. Early diagnosis at the prodromal stage is an important topic of current research. Significant …
R Ishii, L Canuet, Y Aoki, M Hata, M Iwase… - …, 2018 - karger.com
Healthy aging is associated with impairment in cognitive information processing. Several neuroimaging methods such as functional magnetic resonance imaging, positron emission …
Neural synchrony is intricately balanced in the normal resting brain but becomes altered in Alzheimer's disease (AD). To determine the neurophysiological manifestations associated …
C Babiloni, F Vecchio, R Lizio, R Ferri… - Journal of …, 2011 - content.iospress.com
Physiological brain aging is characterized by a combination of synaptic pruning, loss of cortico-cortical connections and neuronal apoptosis that provoke age-dependent decline of …
BACKGROUND: Successful early detection of mild cognitive impairment (MCI) and Alzheimer's disease demands the identification of biomarkers capable of distinguishing …
An extensive electrophysiological literature has proposed a pathological 'slowing'of neuronal activity in patients on the Alzheimer's disease spectrum. Supported by numerous …